Video

Institutional Perspectives in Type 2 Diabetes: Contemporary Approaches to Insulin Treatment

Dr. Jennifer Green led a panel in discussing new treatments and topics in diabetes care.

Recently, Jennifer B. Green, MD, Duke Health, led a 4 person panel of Duke doctors on emerging topics in diabetes management.

The June 22 symposium, called Institutional Perspectives in Type 2 Diabetes: Contemporary Approaches to Insulin Treatment, was part of HCPLive's State of the Science program.

Green kicked the program off with a discussion on the role of insulin therapy in contemporary diabetes management. That was followed by a talk about insulin initiation by Andrea D Coviello, MD, Duke Health,

Next, Susan E. Spratt, MD, Duke Health, talked about intensification and modification of insulin therapy. The final segment was about integrating technology into insulin management, led by Hiba Abou Assi, MD, Duke Health.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.